Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Prevention and Early Treatment of Acute Lung Injury Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (PETAL VIOLET-BioLINCC)

ABSTRACT: Prevention and Early Treatment of Acute Lung Injury Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (PETAL VIOLET-BioLINCC)

PROVIDER: PRJNA1205807 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Prevention and Early Treatment of Acute Lung Injury Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (PETAL VIOLET-BioLINCC)

Project description:Prevention and Early Treatment of Acute Lung Injury Network – Vitamin D to Improve Outcomes by Leveraging Early Treatment (PETAL VIOLET-BioLINCC)

| PRJNA1205808 | ENA

Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS)(PETAL CLOVERS-BioLINCC)

Project description:Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS)(PETAL CLOVERS-BioLINCC)

| PRJNA1269653 | ENA

Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS)(PETAL CLOVERS-BioLINCC)

Project description:Prevention and Early Treatment of Acute Lung Injury (PETAL) Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS)(PETAL CLOVERS-BioLINCC)

| PRJNA1269654 | ENA

Prevention and Early Treatment of Acute Lung Injury (PETAL) Acetaminophen in Sepsis: Targeted Therapy to Enhance Recovery (ASTER)(PETAL ASTER-BioLINCC)

Project description:Prevention and Early Treatment of Acute Lung Injury (PETAL) Acetaminophen in Sepsis: Targeted Therapy to Enhance Recovery (ASTER)(PETAL ASTER-BioLINCC)

| PRJNA1215461 | ENA

Prevention and Early Treatment of Acute Lung Injury (PETAL) Acetaminophen in Sepsis: Targeted Therapy to Enhance Recovery (ASTER)(PETAL ASTER-BioLINCC)

Project description:Prevention and Early Treatment of Acute Lung Injury (PETAL) Acetaminophen in Sepsis: Targeted Therapy to Enhance Recovery (ASTER)(PETAL ASTER-BioLINCC)

| PRJNA1215462 | ENA

Prevention and Early Treatment of Acute Lung Injury Network – Reevaluation of Systemic Early Neuromuscular Blockade (PETAL ROSE-BioLINCC)

Project description:Prevention and Early Treatment of Acute Lung Injury Network – Reevaluation of Systemic Early Neuromuscular Blockade (PETAL ROSE-BioLINCC)

| PRJNA1205806 | ENA

Prevention and Early Treatment of Acute Lung Injury Network – Reevaluation of Systemic Early Neuromuscular Blockade (PETAL ROSE-BioLINCC)

Project description:Prevention and Early Treatment of Acute Lung Injury Network – Reevaluation of Systemic Early Neuromuscular Blockade (PETAL ROSE-BioLINCC)

| PRJNA1205805 | ENA

Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment Resistance

Project description:Leveraging Medulloblastoma Clonal Dynamics to Overcome Treatment Resistance

| PRJNA1309589 | ENA

affy_petaldvt_lyon_rose: Flower/Petal initiation and development in roses

Project description:affy_petaldvt_lyon_rose. The objective is to identify genes involved in petal development in rose. We aim at identifying genes whose expression correlates with flower opening and scent emission. In this study, we used a microarray approach to compare the transcriptome of a scented rose flower (PF) versus non-scented rose flower (RF). Samples (petal tissues) were collected at the same time early in the afternoon. Total RNA was extracted using the Plant RNA kit (Macherey Nagel), and then used to hybridize Rosa-Affymetrix microarrays. Keywords: scented vs non-scented flowers

2011-09-01 | GSE18357 | GEO

Expression analysis of chicken chorioretinal tissues in control and myopic eyes with or without violet light

Project description:To find the possible molecular mechanism of myopia protection by violet light, we performed expression microarray analysis of chick chorioretinal tissue. The mRNA were obtained at day 13 from the following four groups: control eyes with or without violet light exposure and covered eyes with or without violet light exposure, and then the gene expression pattern was compared among them. Principle component analysis, which is to find major patterns of variability in gene expression, was performed and we found that the largest gene population (PC1, positive: n = 138, negative: n = 292) was affected by violet light treatment. On the other hand, the second largest gene population (PC2, positive: n = 120, negative: n = 23) was affected in the eyes covered with a plastic lens. The previously reported myopia-related genes such as Bmp2, Ednrb, Fgf2, Igf1, Il18, Irbp, Lumican, Sfrp1, Tgfb1, Vegfa, Vip, and Wnt2b were not found in the PC1 group in vivo, which indicates that they responded less to violet light. In the PC1 group, only one myopia protective gene, EGR1 (ZENK, zif268), was found among the previously reported myopia related genes.

2017-03-08 | GSE90118 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data